Search Results 621-630 of 21422 for anti-TNF drugs

  1. Sulfamethoxazole And Trimethoprim (Oral Route) Precautions - Mayo Clinic

    The results of some tests may be affected by this medicine. Patients receiving anticonvulsant treatment (medicines to prevent seizures) may be at risk for a ...

  2. Tryptophan (Oral Route) Before Using - Mayo Clinic

    There is no specific information comparing use of L-tryptophan in the elderly with use in other age groups. Drug Interactions. Although certain medicines should ...

  3. Umeclidinium And Vilanterol (Inhalation Route) Description and Brand Names - Mayo Clinic

    Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the ...

  4. Ebola Zaire Vaccine, Live (Intramuscular Route) Before Using - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Adalimumab; Alemtuzumab ...

  5. Antithymocyte Globulin Rabbit (Intravenous Route) Precautions - Mayo Clinic

    While you are being treated with anti-thymocyte globulin (rabbit), and after you stop treatment with it, it is important to see your doctor about the ...

  6. Corticotropin (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Repository corticotropin injection is used to treat ...

  7. Undecylenic Acid (Topical Route) Description and Brand Names - Mayo Clinic

    However, compound undecylenic acid generally has been replaced by newer and more effective medicines for the treatment of fungus infections.

  8. Pegfilgrastim-Bmez (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Pegfilgrastim-bmez injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

  10. Nilutamide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...